Latest news
Loading news…
Redpin Therapeutics is a preclinical stage gene therapy company that develops chemogenetics platform designed for nervous system diseases.
Redpin Therapeutics was acquired by Kriya Therapeutics in 2022.
Total Funding
Available in Pro Last Funding
Available in Pro Acquisitions
0
Monthly Visits
Available in Pro Contacts
7
Company Details
Funding & Financials
Pro- Total funding
- Funding rounds
- Last funding
- Last funding type
- Last funding date
- Funding status
- Total equity funding
- Revenue range
Web Traffic
Pro- Monthly visits
- Global traffic rank
- 6-mo avg visits
- Visit duration (s)
- Pages / visit
- Bounce rate
- Rank change (mo)
Company Info
- Org types
- company
- HQ
- New York, United States
- Diversity spotlight
- Women Founded; Women Led
Key People at Redpin Therapeutics
Chief Technical Operations Officer
President and Founder
7
professional contacts at Redpin Therapeutics
Contact execs at Redpin Therapeutics →Explore 200,000+ acquisitions — free
Filter the full database across sectors, companies, dates, and deal sizes. No signup, no paywall.
Recent News related to Redpin Therapeutics
Loading news…
FAQs about Redpin Therapeutics
People who checked this page also checked these
Browse the full Acquirezy directory.